High Intensity Focused Ultrasound (HIFU) for Parathyroid Adenoma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01291498|
Recruitment Status : Terminated (The manufacturer is not currently supporting research in this indication.)
First Posted : February 8, 2011
Results First Posted : June 25, 2014
Last Update Posted : December 18, 2017
|Condition or disease||Intervention/treatment||Phase|
|Parathyroid Adenomas||Device: High Intensity Focused Ultrasound||Not Applicable|
Primary hyperparathyroidism is a common endocrine condition in which one or more of the four parathyroid glands in the neck releases too much parathyroid hormone (PTH). this leads to excess calcium in the blood and if untreated it can cause osteoporosis, kidney stone formation, deterioration of kidney function and disturbance in heart rhythm. Surgery to remove all or part of the affected gland(s) is expected to cure 95% of such patients. In current practice all such patients undergo localisation techniques using sestamibi scanning and neck ultrasonography to demonstrate the position of the enlarged/overactive parathyroid gland. These radiological tests are positive in some two thirds of patients, who can be operated through a minimally invasive procedure focused on the exact localisation pinpointed by the scans.
This study uses a procedure that does not require a surgical incision. Precise imaging of the parathyroid glands allows the exact position of the tumour to be found from outside the body. A High Intensity Focused Ultrasound beam produces heat, but only in a small specific area. Exact positioning of the ultrasound beam targets the tumour cells and kills them without harming the surrounding healthy tissues.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||High Intensity Focused Ultrasound (HIFU) for Parathyroid Adenoma|
|Study Start Date :||April 2011|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||June 2013|
High Intensity Focused Ultrasound. This is not a comparative study
Device: High Intensity Focused Ultrasound
One or two HIFU sessions
Other Name: TH-One HIFU device
- Eucalcaemia [ Time Frame: 12 months post-treatment ]Calcium in the blood is measured from venepuncture
- Eucalcaemia [ Time Frame: Six weeks post-treatment.Six month data were also intended to be reported, however, six month data were not analyzed because only one subject was entered and this subject was withdrawn from the study before six months after treatment. ]Ca in plasma
- Voice Morbidity [ Time Frame: Up to one year post-treatment ]Voice Handicap Index. 30 questions rated on a five point scale from 'never' to 'always' and an overall score from 1 'normal' to 10 'severely impaired'
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01291498
|John Radcliffe Hospital|
|Oxford, United Kingdom, OX3 9DU|
|Principal Investigator:||Radu Mihai||Oxford University Hospitals NHS Trust|